Information Provided By:
Fly News Breaks for April 12, 2017
EW
Apr 12, 2017 | 08:15 EDT
Guggenheim analyst Chris Pasquale added Edwards Lifesciences (EW) to the Best Ideas List saying he sees the potential for rising estimates and improving sentiment to drive a catch-up trade over the next few months as expectations have overshot to the downside. Pasquale also said a recent physician survey adds support to his views that the risk to US TAVR numbers is to the upside this year starting in Q1. The analyst rates Edwards Lifesciences a Buy with a $120 price target.
News For EW From the Last 2 Days
There are no results for your query EW